While other studies investigated the effect of variable amounts of injected ligand on the tumor uptake of conventional PSMA radioligands [26–29], this study showed for the first time how the molar ligand amount affected the uptake of an albumin-binding radioligand. Here, ALB is linked to neoplasm.